PRNewsWire
20 Nov 2026, 18:40 UTC · 2h ago
What Should Tenax Therapeutics, Inc. Investors Know After 89.77% Stock Drop? The Law Offices of Frank R.
Impact · against what's priced in
The news is immaterial for LEN, as the litigation mentioned targets Tenax Therapeutics, not Lennar. For TENX, the news confirms a devastating loss of value already reflected in the 89.77% price collapse, with only minor new detail regarding the lead plaintiff deadline.
- LEN+0.00
Doesn't touch the price's assumptions
- In context
The article discusses a lawsuit against Tenax Therapeutics; there is no mention of Lennar's operations or financial health.





